| Literature DB >> 34307053 |
Ben Ponvilawan1, Nipith Charoenngam2,3,4.
Abstract
Entities:
Keywords: Hyperuricemia; PTH; Parathyroid hormone; Uric acid; Vitamin D
Year: 2021 PMID: 34307053 PMCID: PMC8283022 DOI: 10.1016/j.jcte.2021.100263
Source DB: PubMed Journal: J Clin Transl Endocrinol ISSN: 2214-6237
Fig. 1Schematic representation of the interplay of vitamin D, parathyroid hormone and uric acid. Uric acid inhibits the expression of the CYP27B1 gene, which encodes the enzyme 1α-hydroxylase that converts 25-hydroxyvitamin D into 1,25-dihydroxyvitamin D at the renal proximal tubule. 1,25-dihydroxyvitamin D inhibits parathyroid hormone secretion at the parathyroid glands directly and indirectly by stimulating intestinal calcium absorption leading to a transient increase in serum ionized calcium. Parathyroid hormone inhibits the ATP-binding cassette transporter G2 transporter, which, in turn, results in decreased urinary uric acid excretion and hyperuricemia. Abbreviations: 1α-OHase: 1α-hydroxylase; 25-OHase: 25-hydroxylase; 1,25(OH)2D: 1,25-dihydroxyvitamin D; 25(OH)D: 25-hydroxyvitamin D; ABCG2: ATP-binding cassette transporter G2 transporter; PTH: parathyroid hormone.